Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/18/2017 09/19/2017 09/20/2017 09/21/2017 09/22/2017 Date
221.54(c) 215(c) 210(c) 202.66(c) 204.65(c) Last
2 971 094 5 416 088 5 474 505 5 878 871 3 895 301 Volume
+0.57% -2.95% -2.33% -3.50% +0.98% Change
More quotes
Financials ($)
Sales 2017 15 902 M
EBIT 2017 7 635 M
Net income 2017 -3 341 M
Debt 2017 24 293 M
Yield 2017 1,44%
Sales 2018 16 759 M
EBIT 2018 8 183 M
Net income 2018 -12,1 M
Debt 2018 21 987 M
Yield 2018 1,48%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 5,83x
EV / Sales2018 5,39x
Capitalization 68 416 M
More Financials
Company
Allergan Plc engages in the research, development, and manufacture of pharmaceutical products.It operates through the following segments: US Specialized Therapeutics; US General Medicine, and International.The US Specialized Therapeutics segment includes sales and expenses relating to branded... 
Sector
Pharmaceuticals
Calendar
11/01Earnings Release
More about the company
Surperformance© ratings of Allergan plc
Trading Rating : Investor Rating :
More Ratings
Latest news on ALLERGAN PLC
09/22 ALLERGAN : Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) S..
09/22 ALLERGAN : New Data from CENTAUR Phase 2b Clinical Study Supports Continued Deve..
09/21 ALLERGAN : Allergan Innovation Recognized With Three 2017 Allure Best of Beauty ..
09/20DJMakers Of Opioids Are Asked For Data -- WSJ
09/19DJStates Push Ahead With Investigation Into Opioid Painkillers
09/19 ALLERGAN : Innovation Recognized With Three 2017 Allure Best of Beauty Breakthro..
09/19 Attorney General Cynthia Coffman joins expanded probe into opioid manufacture..
09/16 AMGEN : A Biosimilar Cure for Sky-High Cancer Drug Prices
09/15 IMPRIMIS PHARMACEUTICALS : Releases Statement Regarding Allergan Lawsuit
09/15 Indivior files lawsuits against Suboxone generic rivals
More news
Sector news : Pharmaceuticals - NEC
09/22DJCorrection to Sept. 7 Harvey Rebuilding Article
09/22 Korea tensions keep European shares in check before Germany vote
09/22 Bettencourt death stirs speculation about L'Oreal ownership
09/22 China online insurer ZhongAn prices Hong Kong IPO at top end, raises $1.5 bil..
09/21DJPFIZER : Files Antitrust Lawsuit Against J&J -- WSJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
07:50aAllergan Receives Refusal to File Letter from FDA for Vraylar® (.. 
05:28aNative American tribe moves to dismiss Allergan patent case -  
03:46aAllergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) .. 
09/22Allergan caps a bad day with news the FDA has kicked back a supplemental appl.. 
09/22Allergan receives refusal to file letter from FDA for Vraylar:  
More tweets
Qtime:194
News from SeekingAlpha
09/22 FDA rejects Allergan's application for expanded use of antipsychotic med Vray..
09/22 Allergan Is A Bargain
09/22 Allergan's Cenicriviroc shows mixed results in mid-stage NASH study
09/21 Continued Trouble Ahead For Ardelyx
09/21 CRISPR FIELD PATENT FIGHT EXTENDED : Focus On Science, Time Frames, Risks
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | AGN | IE00BY9D5467 | 4-Traders
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 269 $
Spread / Average Target 32%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC0.00%68 416
JOHNSON & JOHNSON15.63%353 617
NOVARTIS11.88%223 850
ROCHE HOLDING LTD.6.19%221 926
PFIZER10.81%214 206
MERCK AND COMPANY11.75%178 914